Antibody treatment for Long COVID symptoms
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a lab-made antibody (sipavibart) can reduce Long COVID symptoms. It is for people who developed Long COVID after a confirmed COVID infection and still have moderate to severe fatigue and other ME/CFS-like symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You had a positive COVID test (PCR or antigen) that started your illness.
- Your COVID symptoms began on or before August 31, 2023, and you have had Long COVID symptoms for more than 3 months after that infection.
- Your current symptoms match the case definition for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
- You have a PROMIS-29 score of 60 or more (meaning moderate to severe symptom burden).
- You do not have any of the listed medical conditions or recent treatments that would exclude you from the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether immune-modulating treatments can help people with long covid, especially those with ongoing heart, cough, or fatigue symptoms. It aims to see if calming the immune system reduces symptoms and improves daily life.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
This trial tests if a low dose of sirolimus, a medicine that calms the immune system, can help people with long COVID. If you have had long COVID symptoms for at least 6 months, like severe fatigue, brain fog, or chest pain, you may be able to join.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
This study tests whether a combination of antiviral medications can help reduce Long COVID symptoms by targeting viruses that may stay in the body. If you have Long COVID, this treatment might help you feel better.
This study tests whether giving a nasal spray of immunoglobulin (antibodies) helps people with long covid who also have a weakened immune system. It may improve symptoms like fatigue or brain fog.
Hear when a new Post-COVID / Long-COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.